NHS England’s director of specialised commissioning and interim commercial medicines director, John Stewart, said: “After nearly 15 years without a new treatment for this type of advanced cervical cancer, this first immunotherapy marks a significant step forward that will provide hundreds of people with precious time with their loved ones.